Inventurus Knowledge Solutions is scheduled to begin its public subscription from December 12 to December 16. The company, which offers healthcare support services, has set a price range of ₹1,265-1,329 per share for its initial public offering (IPO) valued at ₹2,498 crores. Rekha Jhunjhunwala-backs Inventurus Knowledge Solutions.
The company has decreased its issue size, which now includes an Offer For Sale (OFS) of 1.88 crore equity shares from promoters and individual shareholders, without any new issue component. Previously, the OFS size was 2.82 crore, according to the draft documents.
At the upper price point, the company’s initial public offering is projected to be ₹2,498 crore. This would give it a market capitalization exceeding ₹22,800 crore.
Inventurus Knowledge Solutions, founded in 2006, is a tech-driven healthcare solutions provider focused on the US market.
IKSL’s care enablement platform supports healthcare enterprises in the US, Canada, and Australia. The company does this by streamlining administrative, clinical, and operational tasks, enhancing clinical outcomes, optimizing revenue, reducing burnout. Additionally, it also assists by enabling value-based care through digital health solutions. As of September 30, 2024, IKSL served 778 healthcare organizations
Inventurus Knowledge Solutions: Revenue Model
i. a percentage of payments collected by clients,
ii. transaction volume, and
iii. Monthly fees (e.g., per physician).
IKSL benefits as clients grow by acquiring medical groups, opening clinics, hiring physicians, and increasing patient volumes.
Some Of The Top Board Members Of The Company Include
- Berjis Minoo Desai is the Chairman and Non-Executive Director of the company,
- Sachin Gupta is a Promoter and Whole-time Director on the Board of the company, as well as the Chief Executive Officer of IKS Inc.
- Joseph Benardello is a Non-Executive Director on the Board of the company
- Dr. Mary Earley Klotman serves as a Non-Executive Director on the Board of the company.
- Amit Goela is a Non-Executive Nominee Director on the Board, associated with the company since 2021
IKSL’s revenue grew from ₹764 crore in FY22 to ₹1,818 crore, at a CAGR of 54%, while PAT rose at a CAGR of 26% to ₹371 crore. In FY24, the EBITDA margin stood at 28%, while the PAT margin was 20.4%.
ALSO READ: Ayushman Vay Vandana Card: Rs 5 Lakh Free Health Cover For Senior Citizens! – Here’s How To Apply
